Fig. 2From: Effectiveness and safety of pegylated liposomal doxorubicin versus epirubicin as neoadjuvant or adjuvant chemotherapy for breast cancer: a real-world studyKaplan-Meier curves of disease-free survival (DFS) of among patients who received adjuvant chemotherapy. (A) DFS before PSM, (B) DFS after PSM. PLD, pegylated liposomal doxorubicinBack to article page